Evidence map›Paper›PMID 41762364›Full record

ArticleLifetime data analysis2026

Optimal designs for discrete-time survival models with competing risks.

XiaoDong Zhou, YunJuan Wang, RongXian Yue, Weng Kee Wong

Abstract read
In one paragraph

Article in Lifetime data analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

XiaoDong ZhouSchool of Statistics and Data Science, Shanghai University of International Business and Economics, Shanghai, 201620, China.
YunJuan WangSchool of Statistics and Mathematics, Shanghai Lixin University of Accounting and Finance, Shanghai, 201620, China.
RongXian YueSchool of Arts and Sciences, Fuyao University of Science and Technology, Fuzhou, 350109, China.
Weng Kee WongDepartment of Biostatistics, University of California, Los Angeles, Los Angeles, CA, 90095-1772, USA. wkwong@ucla.edu.ORCID http://orcid.org/0000-0001-5568-3054

Funding

Ministry of Education MOE-108-YSFMS-0004-012-P1National Natural Science Foundation of China 11871143National Natural Science Foundation of China 11971318
6 · The paper itself

Abstract

Current methodological research on randomized controlled trial design has predominantly focused on studies with a single primary endpoint. However, many trials in practice involve multiple competing target events. The optimal designs for survival trials with competing target events have not been systematically addressed in the statistical literature. This paper fills this significant gap by developing design methodologies for randomized discrete-time-to-event trials with competing endpoints. We derive the Fisher information matrix for the general discrete-time survival model (DTSM) by transforming the original discrete-time survival data into proper multinomial responses. By introducing a cost-based generalized [Formula: see text]-optimal design criterion, we identify various types of optimal designs for estimating the treatment effects. Under the assumption of a parametric competing risks model for the underlying survival process, we demonstrate that the optimal treatment allocation scheme is critically influenced by the parameter values within this model. Our methodology is applied to the redesign of the SANAD trial, which examines withdrawal times from anti-epileptic drugs, thereby highlighting the advantages of our optimal design strategies. A key finding is that assigning subjects equally to the different groups in a two-arm DTSM trial with competing risks is generally a favorable choice, unless the hazard rates over the duration of the trial in both groups are low.

Indexed as

Models, StatisticalRandomized Controlled Trials as TopicResearch DesignAnticonvulsantsComputer SimulationHumansRiskSurvival AnalysisAnticonvulsantsCompeting risksDiscrete-time survival modelLongitudinal studyParametric competing risks modelTime-varying treatment effects.

Identifiers

PMID41762364
PMCPMC12950086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.